GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Sep 16, 2025, 12:46 PM EDT
GB Sciences Revenue
GB Sciences had revenue of $97.24K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $97.24K.
Revenue (ttm)
97.24K
Revenue Growth
n/a
P/S Ratio
0.84
Revenue / Employee
48.62K
Employees
2
Market Cap
81.41K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | - | - | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 2.12M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |
GB Sciences News
- 2 years ago - Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform - GlobeNewsWire
- 3 years ago - Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit - GlobeNewsWire
- 3 years ago - Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article - GlobeNewsWire